Skip to main content
Premium Trial:

Request an Annual Quote

MDS Sciex Reports 4-Percent Rise in Organic Q4 Revenue

NEW YORK (GenomeWeb News) — MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
 
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
 
Driving revenue were the small molecule and applied markets and in Europe, MDS said.
 
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
 
R&D spending remained flat at $4 million.  
 
The company did not break out earnings or a balance sheet for the unit.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.